Author: Uribarri, Aitor; Núñez-Gil, Iván J.; Aparisi, Alvaro; Becerra-Muñoz, Victor M.; Feltes, Gisela; Trabattoni, Daniela; Fernández-Rozas, Inmaculada; Viana-Llamas, MarÃa C.; Pepe, Martino; Cerrato, Enrico; Capel-Astrua, Thamar; Romero, Rodolfo; Castro-MejÃa, Alex F.; El-Battrawy, Ibrahim; López-PaÃs, Javier; D’Ascenzo, Fabrizio; Fabregat-Andres, Oscar; BardajÃ, Alfredo; Raposeiras-Roubin, Sergio; MarÃn, Francisco; Fernández-Ortiz, Antonio; Macaya, Carlos; Estrada, Vicente
Title: Impact of renal function on admission in COVID-19 patients: an analysis of the international HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID 19) Registry Cord-id: taw8wi2g Document date: 2020_6_29
ID: taw8wi2g
Snippet: BACKGROUND: Coronavirus disease 2019 (COVID-19) is a disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Despite its international aggressive extension, with a significant morbidity and mortality, the impact of renal function on its prognosis is uncertain. METHODS: Analysis from the international HOPE-Registry (NCT04334291). The objective was to evaluate the association between kidney failure severity on admission with the mortality of patients with SARS-CoV-2 infecti
Document: BACKGROUND: Coronavirus disease 2019 (COVID-19) is a disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Despite its international aggressive extension, with a significant morbidity and mortality, the impact of renal function on its prognosis is uncertain. METHODS: Analysis from the international HOPE-Registry (NCT04334291). The objective was to evaluate the association between kidney failure severity on admission with the mortality of patients with SARS-CoV-2 infection. Patients were categorized in 3 groups according to the estimated glomerular filtration rate on admission (eGFR > 60 mL/min/1.73 m(2), eGFR 30–60 mL/min/1.73 m(2) and eGFR < 30 mL/min/1.73 m(2)). RESULTS: 758 patients were included: mean age was 66 ± 18 years, and 58.6% of patient were male. Only 8.5% of patients had a history of chronic kidney disease (CKD); however, 30% of patients had kidney dysfunction upon admission (eGFR < 60 mL/min/1.73 m(2)). These patients received less frequently pharmacological treatment with hydroxychloroquine or antivirals and had a greater number of complications such as sepsis (11.9% vs 26.4% vs 40.8%, p < 0.001) and respiratory failure (35.4% vs 72.2% vs 62.0%, p < 0.001) as well as a higher in-hospital mortality rate (eGFR > 60 vs eGFR 30-60 vs and eGFR < 30, 18.4% vs 56.5% vs 65.5%, p < 0.001). In multivariate analysis: age, hypertension, renal function, 0(2) saturation < 92% and lactate dehydrogenase elevation on admission independently predicted all-cause mortality. CONCLUSIONS: Renal failure on admission in patients with SARS-CoV-2 infection is frequent and is associated with a greater number of complications and in-hospital mortality. Our data comes from a multicenter registry and therefore does not allow to have a precise mortality risk assessment. More studies are needed to confirm these findings. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s40620-020-00790-5) contains supplementary material, which is available to authorized users.
Search related documents:
Co phrase search for related documents- absence presence and acute deterioration: 1
- absence presence and admission aki: 1
- absence presence and local committee: 1, 2
- absence presence and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63
- absence presence and logistic regression analysis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- absence presence and logistic regression model: 1, 2, 3, 4, 5, 6, 7
- absence presence and lopinavir ritonavir: 1, 2
- absence presence and lopinavir ritonavir antiviral: 1
- absence presence and low incidence: 1, 2
- absence presence and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- absence presence and lung parenchyma: 1
- absence presence and lymphopenia dimer: 1, 2
- acute aki kidney injury and admission aki: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- acute aki kidney injury and admission aki development: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- acute aki kidney injury and admission egfr: 1, 2, 3, 4, 5, 6
- acute aki kidney injury and admission renal function: 1, 2, 3, 4
- acute aki kidney injury and admission treatment: 1, 2, 3, 4
Co phrase search for related documents, hyperlinks ordered by date